NEO
Price:
$11.15
Market Cap:
$290.37M
NeoGenomics, Inc. specializes in providing cancer-focused diagnostic and testing services through an extensive network of laboratories located across the United States, Europe, and Asia. The company operates through two distinct divisions: Clinical Services and Pharma Services. Its comprehensive offerings cater to a diverse clientele, including hospitals, reference laboratories, pathologists, oncologists, clinicians, pharmaceutical companies, and researchers. NeoGenomics' advanced testing capabilities encompass cytogenetics, which examines normal and abnormal chromosomes in relation to disease; fluorescence in-situ hybridization (FISH) for detecting and pinpointing specific DNA sequences and...[Read more]
Industry
Medical - Diagnostics & Research
IPO Date
2004-03-16
Stock Exchange
NASDAQ
Ticker
NEO
According to NeoGenomics, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 4.42. This represents a change of 7.07% compared to the average of 4.13 of the last 4 quarters.
The mean historical Current Ratio of NeoGenomics, Inc. over the last ten years is 4.31. The current 4.42 Current Ratio has changed 10.15% with respect to the historical average. Over the past ten years (40 quarters), NEO's Current Ratio was at its highest in in the March 2021 quarter at 13.91. The Current Ratio was at its lowest in in the December 2016 quarter at 1.32.
Average
4.31
Median
4.41
Minimum
1.32
Maximum
7.81
Discovering the peaks and valleys of NeoGenomics, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 167.38%
Maximum Annual Current Ratio = 7.81
Minimum Annual Increase = -68.07%
Minimum Annual Current Ratio = 1.32
| Year | Current Ratio | Change |
|---|---|---|
| 2025 | 4.26 | 115.38% |
| 2024 | 1.98 | -68.07% |
| 2023 | 6.20 | -7.92% |
| 2022 | 6.73 | -13.85% |
| 2021 | 7.81 | 27.41% |
| 2020 | 6.13 | 34.77% |
| 2019 | 4.55 | 167.38% |
| 2018 | 1.70 | -29.77% |
| 2017 | 2.42 | 84.16% |
| 2016 | 1.32 | -46.78% |
The current Current Ratio of NeoGenomics, Inc. (NEO) is greater than its 3-year, less than than its 5-year, and greater than its 10-year historical averages
3-year avg
4.15
5-year avg
5.40
10-year avg
4.31
NeoGenomics, Inc.’s Current Ratio is greater than Exagen Inc. (3.47), greater than MDxHealth S.A. (1.08), greater than Stereotaxis, Inc. (1.55), greater than Aclaris Therapeutics, Inc. (4.03), greater than Quanterix Corporation (3.72), less than Sagimet Biosciences Inc. (20.34), greater than Sanara MedTech Inc. (2.28), less than Arcturus Therapeutics Holdings Inc. (6.31), greater than Humacyte, Inc. (3.93), less than Alpha Teknova, Inc. (4.59),
| Company | Current Ratio | Market cap |
|---|---|---|
| 3.47 | $112.83M | |
| 1.08 | $27.85M | |
| 1.55 | $179.84M | |
| 4.03 | $520.97M | |
| 3.72 | $146.03M | |
| 20.34 | $211.13M | |
| 2.28 | $190.70M | |
| 6.31 | $198.11M | |
| 3.93 | $177.24M | |
| 4.59 | $225.18M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like NeoGenomics, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like NeoGenomics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Current Ratio?
How can you use the Current Ratio?
What is NeoGenomics, Inc.'s Current Ratio?
How is the Current Ratio calculated for NeoGenomics, Inc. (NEO)?
What is the highest Current Ratio for NeoGenomics, Inc. (NEO)?
What is the 3-year average Current Ratio for NeoGenomics, Inc. (NEO)?
What is the 5-year average Current Ratio for NeoGenomics, Inc. (NEO)?
How does the current Current Ratio for NeoGenomics, Inc. (NEO) compare to its historical average?